Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 USD | +17.66% | +25.04% | +79.19% |
Business Summary
Number of employees: 28
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Celebi
CEO | Chief Executive Officer | 52 | 18-01-31 |
Erin Colgan
DFI | Director of Finance/CFO | 43 | 20-06-30 |
Chief Tech/Sci/R&D Officer | 51 | 19-08-31 | |
Alice Drumheller
CTO | Chief Tech/Sci/R&D Officer | - | 18-07-31 |
Michael Biega
IRC | Investor Relations Contact | - | 22-05-31 |
Stephanie Krebs
PRN | Corporate Officer/Principal | - | 10-31 |
General Counsel | - | 22-06-30 | |
Bao Le
LAW | General Counsel | - | 21-05-31 |
Corporate Officer/Principal | 44 | 22-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
William Ringo
CHM | Chairman | 78 | 22-03-07 |
John Celebi
CEO | Chief Executive Officer | 52 | 18-01-31 |
Bob Holmen
BRD | Director/Board Member | 60 | 16-12-31 |
Thomas Ricks
BRD | Director/Board Member | 70 | 14-12-31 |
Deneen Vojta
BRD | Director/Board Member | 59 | 20-01-28 |
James Peyer
BRD | Director/Board Member | 37 | 19-12-31 |
Kristian Humer
BRD | Director/Board Member | 49 | 21-07-29 |
Jessie English
BRD | Director/Board Member | 60 | 21-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 25,070,980 | 16,384,834 ( 65.35 %) | 0 | 65.35 % |
Company contact information
Sensei Biotherapeutics, Inc.
1405 Research Boulevard` Suite 125
20850, Rockville
+240 243 8000
http://senseibio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+79.19% | 25.57M | |
-2.20% | 102B | |
+2.35% | 96.09B | |
+2.13% | 22.28B | |
-16.91% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.86% | 16.09B | |
+5.26% | 13.83B | |
+33.27% | 11.97B |
- Stock Market
- Equities
- SNSE Stock
- Company Sensei Biotherapeutics, Inc.